Xia X - Search Results

1

Oncoplastic Breast-Conserving Surgery for Upper Inner Quadrant Breast Cancer Using Pedicled Pectoralis Major Myofascial Flap.

Hu JJ, Qin C, Liu S, Zhu M, Xia X, Liang C, Mao J, Zhang F, Yu Y. Hu JJ, et al. Among authors: xia x. Cancer Manag Res. 2024 Dec 10;16:1747-1752. doi: 10.2147/CMAR.S472263. eCollection 2024. Cancer Manag Res. 2024. PMID: 39678040 Free PMC article.

2

Dissection of Level III Axillary Lymph Nodes in Breast Cancer.

Hu J, Xia X, Yang H, Yu Y. Hu J, et al. Among authors: xia x. Cancer Manag Res. 2021 Feb 26;13:2041-2046. doi: 10.2147/CMAR.S290345. eCollection 2021. Cancer Manag Res. 2021. PMID: 33664591 Free PMC article. Review.

3

The expression profile of Gasdermin C-related genes predicts the prognosis and immunotherapy response of pancreatic adenocarcinoma.

Xia XH, Yin WJ, Mao JF, Liu P, Qin CD, Hu JJ, Liu SY, Wang CM, Zou DH, Yang HJ, Yu Y, Huang J. Xia XH, et al. Am J Cancer Res. 2023 Apr 15;13(4):1240-1258. eCollection 2023. Am J Cancer Res. 2023. PMID: 37168356 Free PMC article.

4

Tanshinone IIA promotes vascular normalization and boosts Sorafenib's anti-hepatoma activity via modulating the PI3K-AKT pathway.

Qin C, Liu S, Zhou S, Xia X, Hu J, Yu Y, Ma D. Qin C, et al. Among authors: xia x. Front Pharmacol. 2023 Jun 1;14:1189532. doi: 10.3389/fphar.2023.1189532. eCollection 2023. Front Pharmacol. 2023. PMID: 37324455 Free PMC article.

5

PIK3C2A is a prognostic biomarker that is linked to immune infiltrates in kidney renal clear cell carcinoma.

Qin C, Liu S, Zhou S, Wang Q, Xia X, Hu J, Yuan X, Wang Z, Yu Y, Ma D. Qin C, et al. Among authors: xia x. Front Immunol. 2023 Mar 30;14:1114572. doi: 10.3389/fimmu.2023.1114572. eCollection 2023. Front Immunol. 2023. PMID: 37063922 Free PMC article.

6

Effects of Gonadotropin-Releasing Hormone Analogs on Ovarian Function Against Chemotherapy-Induced Gonadotoxic Effects in Premenopausal Women With Breast Cancer in China: A Randomized Clinical Trial.

Zong X, Yu Y, Yang H, Chen W, Ding X, Liu S, Li X, Chen X, Jiang C, Xia X, Huang R, Zhu M, Hu J, Liang C. Zong X, et al. Among authors: xia x. JAMA Oncol. 2022 Feb 1;8(2):252-258. doi: 10.1001/jamaoncol.2021.6214. JAMA Oncol. 2022. PMID: 34967844 Free PMC article. Clinical Trial.

7

Breast carcinoma associated with prolactinoma: A case report.

Zheng Y, Mo W, Yu Y, Zou D, He X, Xia X, Hu J. Zheng Y, et al. Among authors: xia x. Cancer Biol Ther. 2017 Mar 4;18(3):132-136. doi: 10.1080/15384047.2017.1294284. Epub 2017 Feb 17. Cancer Biol Ther. 2017. PMID: 28278079 Free PMC article.

8

Editorial: Drug-induced immunogenic cell death patterns and anti-cancer treatment.

Xia X, Ye Z, Ahmad S, Wei Y, Yu Y. Xia X, et al. Front Pharmacol. 2023 Jul 13;14:1252168. doi: 10.3389/fphar.2023.1252168. eCollection 2023. Front Pharmacol. 2023. PMID: 37521475 Free PMC article. No abstract available.

9

ICT1 knockdown inhibits breast cancer cell growth via induction of cell cycle arrest and apoptosis.

Wang C, Liang C, Feng W, Xia X, Chen F, Qiao E, Zhang X, Chen D, Ling Z, Yang H. Wang C, et al. Among authors: xia x. Int J Mol Med. 2017 Apr;39(4):1037-1045. doi: 10.3892/ijmm.2017.2913. Epub 2017 Mar 9. Int J Mol Med. 2017. PMID: 28290601

10

Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance.

Deng Y, Xia X, Zhao Y, Zhao Z, Martinez C, Yin W, Yao J, Hang Q, Wu W, Zhang J, Yu Y, Xia W, Yao F, Zhao D, Sun Y, Ying H, Hung MC, Ma L. Deng Y, et al. Among authors: xia x, xia w. Nat Commun. 2021 Dec 6;12(1):7041. doi: 10.1038/s41467-021-27349-7. Nat Commun. 2021. PMID: 34873175 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,044 results

Search Page

Filters